Lung oncology Clinical Trials in Seattle, WA

As of August 2026, 47 paid clinical trials are recruiting for Lung oncology in Seattle, Washington. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: August 31, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

47 clinical trials for Lung oncology

·Clear filters·

Email me when a new lung oncology trial opens in Seattle, WA.

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

for Breast Carcinoma

Sites in Seattle, Bellevue +462 more locations

Sponsor: Wake Forest University Health Sciences

Sex: All·Age: 18+

Code: NCT06418204·Recruiting·Listed May 2024

Apply to this trial

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

for Non-small Cell Lung Cancer

Sites in Seattle +19 more locations

Sponsor: Institut de Recherches Internationales Servier

Sex: All·Age: 18+

Code: NCT05786924·Phase 1, Phase 2·Recruiting·Listed Mar 2023

Apply to this trial

Exercise Training for the Improvement of Immune Activity and Treatment Outcomes During Immunotherapy for Non-small Cell Lung Cancer, BOOST Trial

for Lung Non-Small Cell Carcinoma

1 location in Seattle

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 18+

Code: NCT06983899·Recruiting·Listed May 2025

Apply to this trial

SX-682 With Pembrolizumab for the Treatment of Metastatic or Recurrent Stage IIIC or IV Non-Small Cell Lung Cancer

for Metastatic Lung Non-Small Cell Carcinoma

1 location in Seattle

Sponsor: University of Washington

Sex: All·Age: 18+

Code: NCT05570825·Phase 2·Recruiting·Listed Oct 2022

Apply to this trial

SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer

for Advanced Lung Non-Small Cell Carcinoma

Drug: Atezolizumab

1 location in Seattle

Sponsor: University of Washington

Sex: All·Age: 18+

Code: NCT07322341·Phase 2·Recruiting·Listed Jan 2026

Apply to this trial

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

for Non-small Cell Lung Cancer

Sites in Seattle, Edmonds +17 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 95

Code: NCT05061550·Phase 2·Recruiting·Listed Sep 2021

Apply to this trial

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

for Non-small Cell Lung Cancer

Drug: Rilvegostomig

Sites in Seattle, Tacoma +63 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06692738·Phase 3·Recruiting·Listed Nov 2024

Apply to this trial

Conditions in Lung oncology (Seattle, WA)

Non-small cell lung cancer (NSCLC)· 44 Lung cancer· 9 Mesothelioma· 4 Small cell lung cancer· 2